Featured News

On May 11, 2015, the Food and Drug Administration (FDA) will conduct a public meeting on Functional GI Disorders Patient-Focused Drug Development. Celiac Disease Foundation was requested by the FDA to provide commentary about the impact of celiac disease on patients’ daily lives, the types of treatment benefit that matter most to patients, and patients’ perspectives on the adequacy of the available therapies.

CDF CEO, Marilyn Geller, will present the celiac patient voice at the May 11 FDA Patient-Focused Drug Development meeting. Have your voice be heard. Complete the CDF Celiac PFDD Survey now.

Celiac Disease Foundation Chief Executive Officer, Marilyn Geller, attended The State of Autoimmune Disease: A National Summit at the National Press Club in Washington, D.C. The Summit explored the current trends in diagnosis, treatment, and therapies, presented by experts in research, environment, advocacy, and patient issues.

On March 30-31st, 2015, Celiac Disease Foundation Chief Executive Officer, Marilyn G. Geller, attended the FDA Public Workshop on Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT3) near Washington,…

Celiac Disease Foundation is pleased to announce our participation in the Autoimmune Research Network, known as ARNet. ARNet is a network of autoimmune disease advocacy organizations that will foster research into celiac…

On March 1 and 2, 2015, Talia Hassid, Celiac Disease Foundation’s Community Coordinator, attended the Digestive Disease National Coalition Public Policy Forum held in Washington DC. The forum gathers representatives from digestive disease organizations across the U.S. together to arrive at a common agenda to influence health care policy in the United States.

On March 23rd, join CDF at The State of Autoimmune Disease: A National Summit at the National Press Club in Washington, DC. The summit will bring together leading experts in research, environment, advocacy and patient issues to explore the most current trends in autoimmune disease diagnosis, treatments and therapies.

Learn from experts from the Celiac Program at Harvard Medical School at the inaugural CEU-based medical and nutrition conference titled “Gluten Free for Life: A Comprehensive Toolkit for Diagnosing and Treating Celiac Disease and Other Gluten-Related Disorders” with separate healthcare professionals and patient tracks.

LOS ANGELES, Calif., Feb. 6, 2015 –Celiac Disease Foundation today sent a letter to California Attorney General Kamala Harris, asking that she issue notifications to GNC Holdings, Inc., Target Corporation, Walgreens and Wal-Mart Stores,…

The Celiac Disease Foundation Medical Advisory Board, together with the National Board of Directors submitted a letter to the U.S. Preventive Services Task Force supporting the North American Society for the Study of Celiac Disease (NASSCD) comments on the Task Force's draft research plan for screening for celiac disease. Among other comments, the NASSCD encouraged the USPSTF to focus on high risk individuals (those who are symptomatic, have associated diseases or a family history) in their research.